Multiple Myeloma Clinical Trials in Salamanca

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Active, not recruiting
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
2022-03-21
Mar 21, 2022
J
Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Daratumumab Subcutaneous (SC) Administration
  • Recombinant Human Hyaluronidase [rHuPH20]) SC Administration
  • Atlanta, Georgia
  • +11 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +145 more
2022-03-24
Mar 24, 2022
J
Active, not recruiting
  • Multiple Myeloma
  • Southington, Connecticut
  • +63 more
2022-03-24
Mar 24, 2022
J
Recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +113 more
2022-03-24
Mar 24, 2022
G
Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
2022-02-25
Feb 25, 2022
O
Terminated
  • Multiple Myeloma
  • Melphalan flufenamide (Melflufen)
  • +3 more
  • Boston, Massachusetts
  • +15 more
2022-03-04
Mar 4, 2022